Genome-wide association identifies multiple ulcerative colitis susceptibility loci
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn’s disease susceptibility loci
Dysbiosis of fecal microbiota in Crohn’s disease patients as revealed by a custom phylogenetic microarray
Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease
Animal Protein Intake and Risk of Inflammatory Bowel Disease: The E3N Prospective Study (France)
The CHOICE trial: adalimumab demonstrates safety, fistula healing, improved quality of life and increased work productivity in patients with Crohn’s disease who failed prior infliximab therapy